Specify a stock or a cryptocurrency in the search bar to get a summary
SWK Holdings Corp
SWKHSWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. This segment also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. The Pharmaceutical Development segment provides customers pharmaceutical development, formulation, and manufacturing services, as well as formulation solutions built around its proprietary oral drug delivery technologies, the Peptelligence platform. It also offers intellectual property licensing business. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas. Address: 5956 Sherry Lane, Dallas, TX, United States, 75225
Analytics
WallStreet Target Price
24 USDP/E ratio
17.7872Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SWKH
Dividend Analytics SWKH
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SWKH
Stock Valuation SWKH
Financials SWKH
Results | 2019 | Dynamics |